logo

For the Inventor, By the Inventor

Greenfield, IN, United States of America

Elanco US Inc.

Calculating rank
USPTO Granted Patents = 52

% Expired Patents = 3.8



Trademarks = 114

Forward Citations = 11

Loading Chart...
Loading Chart...

85 inventors (with patents filed for the assignee):

goldMedal Shyr Jiann Li (8 out of 15 patents)

silverMedal Lam Nguyen (8 out of 15 patents)

bronzeMedal Hangjun Zhan (8 out of 15 patents)

4.  Peter Connor Canning (7 out of 11 patents)

5.  Kim Gene Friesen (5 out of 36 patents)

6.  Nickolas Knudsen (4 out of 7 patents)

7.  Ran Song (4 out of 5 patents)

8.  Stephen Wu (4 out of 4 patents)

9.  Jingdan Hu (4 out of 7 patents)

10.  Cory T Herr (3 out of 3 patents)

11.  John Charles Kube (3 out of 3 patents)

12.  Jerold Scott Teeter (3 out of 3 patents)

13.  James David Pancook (3 out of 10 patents)

14.  Lillian Skidmore (3 out of 13 patents)

15.  Nick Knudsen (3 out of 37 patents)


Core Competencies:
JAK Inhibitors
Anti-IL31 Antibodies
Bovine Emissions
Pegylated Interferon
Porcine G-CSF
Chimeric Antibodies
Granulocyte Colony Stimulating Factor
Vaccine Virus
Transdermal Formulations
Animal Waste Treatment
Heartworm Resistance Markers
Lyophilized Formulations

52 patents:

1. 12765577 - Feed additive compositions (2026-10-20),
2. 12714674 - JAK inhibitors having a specific particle size distribution (2026-08-25),
3. 12703753 - NGF antagonists for medical use (2026-08-11),
4. 12691033 - Lyophilized cake in straight-walled vial (2026-07-28),
5. 12677847 - Methods and formulations for reducing bovine emissions (2026-07-14),
6. 12668626 - Anti-IL31 Antibodies for Veterinary Use (2026-06-30),
7. 12655138 - Process for making an isoxazoline compound and intermediate thereof (2026-06-16),
8. 12653897 - PEGYLATED PORCINE INTERFERON AND METHODS OF USE THEREOF (2026-06-16),
9. 12583917 - IL17A Antibodies and Antagonists for Veterinary Use (2026-03-24),
10. 12544336 - Palatable formulations (2026-02-10),
11. 12448438 - Anti-IL31 antibodies for veterinary use (2025-10-21),
12. 12435132 - Anti-IL31 antibodies for veterinary use (2025-10-07),
13. 12428466 - IL4/IL13 receptor molecule for veterinary use (2025-09-30),
14. 12398198 - Parvovirus antibodies for veterinary use (2025-08-26),
15. 12391991 - Markers to predict macrocyclic lactone drug resistance in, the causative agent of heartworm disease (2025-08-19),
Company Overview
Elanco US Inc., headquartered in Greenfield, Indiana, specializes in veterinary pharmaceuticals, focusing on innovative solutions for animal health. The company develops a range of products, including JAK inhibitors and anti-IL31 antibodies, aimed at improving the well-being of livestock and pets. Elanco's research extends to advanced technologies such as pegylated interferon and chimeric antibodies, addressing critical areas like bovine emissions and granulocyte colony stimulating factors. Their commitment to animal health drives ongoing advancements in veterinary medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

Elanco US Inc. USPTO Patent Assignee Logo
52 Patents

#1 in Greenfield, IN

#111 in Indiana

#6,778 in US

#13,579 in the World

Greenfield, IN (US)
Greenfield, IN, United States of America

Elanco US Inc.

Forward Citations = 11

85 inventors:

goldMedal Shyr Jiann Li (8 out of 15 patents)

silverMedal Lam Nguyen (8 out of 15 patents)

bronzeMedal Hangjun Zhan (8 out of 15 patents)

4.  Peter Connor Canning (7 out of 11 patents)

5.  Kim Gene Friesen (5 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elanco US Inc.. Retrieved from https://idiyas.com/company/elanco-us

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…